ENE-COVID is no longer the largest serosurvey

This commit is contained in:
Marc Bevand
2020-10-21 08:56:48 -07:00
parent e549e9b473
commit b6aed826c6
+3 -4
View File
@@ -1,4 +1,4 @@
*Updated: 07 Oct 2020*
*Updated: 21 Oct 2020*
Author: Marc Bevand
@@ -349,7 +349,7 @@ for all regions. For example, in the US the average flu IFR is 0.078%, compared
# Calculating the age-stratified IFR of COVID-19 from the Spanish ENE-COVID study
The largest serological prevalence survey of COVID-19 was conducted by Spain
One of the largest serological prevalence surveys of COVID-19 was conducted by Spain
during the second round of the ENE-COVID study that analyzed 63 564 samples between 18 May
2020 and 01 June 2020. We used its [provisional results][sero] published on 03
June to calculate the overall and age-stratified IFR of COVID-19 with the
@@ -374,8 +374,7 @@ The average IFR for Spain is **1.117%**. However the true IFR may be higher due
to right-censoring, under-reporting of deaths, or low specificity of the serological test;
or the true IFR may be lower due to low sensitivity of the serological test.
The Spanish serological study remains the largest published study available to
this day. The age-stratified IFR was calculated from three sources:
The age-stratified IFR was calculated from three sources:
1. Detailed *prevalence data for age brackets*, from the [serosurvey][sero] (table 1)
1. *Total deaths* and *deaths per age bracket* from the [Ministry of Health's daily report for 29 May][daily] (table 2 and table 3)